Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

ST. LOUIS — The Alzheimer’s Association reports that for the first time, more than 7.2 million Americans aged 65 and older are estimated to be living with Alzheimer’s disease in 2025 — a number ...

Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...

Recognizing the early signs of Alzheimer’s can feel like standing at the edge of an emotional cliff — overwhelming, terrifying and confusing all at once. But knowing how to respond to early ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Dr. Martínez-Lage shares Alzheimer's breakthroughs: why early diagnosis matters, the 4-step treatment plan for autonomy, and ...

It’s hard to cruise your For You feed right now without being faced with yet another testimonial about the perks of taking a creatine supplement. While creatine is the supplement du jour, there is ...

Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...